Tag: Structural Heart

Primary Endpoint Met in Corvia Medical’s Reduce LAP-HF I Study

Privately-held Corvia Medical said its investigational transcatheter structural heart device to treat heart failure has demonstrated success in reducing exercise pulmonary capillary wedge pressure in trial patients. This morning, the company said its device, called the Interatrial Shunt Device (IASD) significantly reduced PCWP at […]

Late-Breaking Data on Abbott’s MitraClip® System Show Continued Benefit for People with Mitral Regurgitation, Most Common Heart Valve Disease

WASHINGTON, March 18, 2017 /PRNewswire/ — Abbott (ABT) today announced favorable one-year outcomes from the largest study of real-world experience for the MitraClip system in transcatheter mitral valve repair (TMVR) procedures in the United States. MitraClip treats people with degenerative […]